Previous 10 | Next 10 |
2024-05-31 15:00:19 ET More on the markets Bitcoin's Fading Action Is A Huge Warning For Stock Market Liquidity S&P 500: It Is All About Liquidity SPY: Time To Be Contrarian And Underweight Hedge funds back at record exposure to Magnificent 7 S&am...
A look at the top 10 most actives in the United States Greenwave Technology Solutions Inc. (GWAV) fell 8.6% to $0.0384 on volume of 89,961,220 shares Nuburu Inc. (BURU) rose 29.4% to $0.207 on volume of 85,213,370 shares Novo Integrated Sciences Inc. (NVOS) rose 139.5% to $1.08 on volume ...
2024-05-31 08:59:26 ET More on Akeso, Merck, etc. Merck Stock: Still Discounted To Graham P/E Merck & Co., Inc. (MRK) BofA Securities 2024 Health Care Conference (Transcript) Merck: The Worst Has Been Avoided (Rating Upgrade) Dividend Roundup: Meta Platfo...
2024-05-30 16:10:00 ET Summary The global market for GLP-1 therapies now looks on pace to top $100 billion. GLP-1 pioneers such as Eli Lilly, Novo Nordisk, could be joined by new players Amgen, Altimmune, Pfizer, Viking, Roche, and privately held Boehringer Ingelheim that have GLP...
2024-05-30 11:22:06 ET More on Eli Lilly, Novo, etc. Novo Nordisk: The Market Is Right, Don't Fight Against It Novo Nordisk: Not The Best Investment Right Now, But A Great Case Study Novo Nordisk: Considerable Growth Beyond Ozempic Lilly's Retevmo gains appro...
2024-05-29 14:13:00 ET More on S&P 500 Index: A Tale Of Two Indices 2024 Election: What We Think For Markets 'True' Inflation Is Higher Than The 'Official' Numbers Dow -1%, S&P and Nasdaq slip as airlines, health insurers weigh; Treasurys extend fall ...
2024-05-29 12:32:44 ET More on Eli Lilly Eli Lilly: Addressing Supply Challenges Should Accelerate Growth Eli Lilly: Great Time To Divest Before It Potentially Crashes Eli Lilly Remains Expensive Here - Minimal Margin Of Safety Ro provides supply tracking fea...
2024-05-29 12:11:20 ET More on Eli Lilly, Novo Nordisk Eli Lilly: Addressing Supply Challenges Should Accelerate Growth SA Asks: Is Eli Lilly or Novo Nordisk a better investment? Novo Nordisk: The Market Is Right, Don't Fight Against It SA Asks: Who...
2024-05-29 10:30:00 ET Summary Harding Loevner is an investment manager that invests primarily in publicly traded global equities. We were founded in 1989 by former managers for the Rockefeller family. Harding Loevner is a Delaware limited partnership. We operate independently of Affi...
2024-05-29 09:25:00 ET Summary Harding Loevner is an investment manager that invests primarily in publicly traded global equities. We were founded in 1989 by former managers for the Rockefeller family. Harding Loevner is a Delaware limited partnership. We operate independently of Affi...
News, Short Squeeze, Breakout and More Instantly...
2024-07-24 06:39:00 ET If you're a dividend investor, you shouldn't bother with stocks that don't raise their payouts. Inflation has drastically chipped away at consumers' purchasing power in recent years, highlighting just how important it is for dividend income to rise over the long run...
2024-07-23 05:48:00 ET Novo Nordisk (NYSE: NVO) is riding the Ozempic/Wegovy train straight to the bank. Eli Lilly (NYSE: LLY) is doing the same with Mounjaro and Zepbound. Both big drugmakers have multibillion-dollar obesity drug franchises that continue to grow rapidly. Sh...
2024-07-18 05:23:00 ET Stock splits can sometimes be an effective way for a company to generate excitement around its stock. It's a sign that the company is doing well, and by lowering the price of the stock through a split, the shares can become more accessible to a wider pool of investo...